HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Bladder cancer

Bladder cancer is a type of cancer that begins in the cells of the bladder, a hollow organ in the pelvic area responsible for storing urine. It is a condition where abnormal cell growth occurs in the lining of the bladder. This form of cancer is more prevalent in older adults, with the majority of cases diagnosed in individuals over the age of 55. However, bladder cancer can affect people of any age. Smoking is a significant risk factor for developing bladder cancer, and other risk factors include exposure to certain chemicals and a family history of the disease. Symptoms of bladder cancer may include blood in the urine, pain during urination, and frequent urination. However, these symptoms can also be indicative of other non-cancerous conditions, making it important to consult a healthcare professional for a proper diagnosis. Diagnosis often involves a combination of medical history review, physical examination, and various tests such as imaging studies and urine analysis. Treatment options for bladder cancer depend on the stage of the disease and may include surgery, chemotherapy, immunotherapy, and radiation therapy.
As with many cancers, early detection and intervention play a crucial role in improving outcomes. Regular check-ups and screenings are essential, especially for individuals with risk factors. Bladder cancer, like any medical condition, requires personalized medical attention, and individuals are encouraged to consult with healthcare professionals to determine the most appropriate course of action based on their specific circumstances.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2027 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2027 - Michael Thompson

Michael Thompson

University of Toronto, Canada
Speaker at International Conference on Clinical & Translational Oncology 2027 - Alain Chapel

Alain Chapel

Institute Of Radiological Protection And Nuclear Safety, France

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Whatsapp